Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | MD at Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished academic physician and internationally recognized expert in breast imaging and diagnostic radiology, known for her leadership in integrating advanced imaging technologies and artificial intelligence into clinical cancer care. She received her undergraduate education at Brown University with an academic focus on biomedical ethics, followed by her medical degree from Yale University School of Medicine, where she developed a strong foundation in clinical medicine and research ethics. Dr. Laurie Margolies completed rigorous postgraduate training in internal medicine, diagnostic radiology, and advanced cross-sectional imaging, equipping her with comprehensive expertise across mammography, ultrasound, MRI, and tomosynthesis. Professionally, Dr. Laurie Margolies has held progressive academic appointments culminating in a full professorship in diagnostic, molecular, and interventional radiology at a leading academic medical center, while simultaneously serving in senior health-system leadership roles including Vice Chair and System Chief for Breast Imaging.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations2177

i10index92

h-index19

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Performance of an Artificial Intelligence Support System on Screening Mammography Cases Proceeding to Stereotactic Biopsy
– Cancers (Open Access)
The Tyrer-Cuzick Risk Model: Is It Effective for All Races?
– Clinical Imaging
Patient Perception of Artificial Intelligence in Breast Imaging: A Pilot Survey Study
– Clinical Imaging
Suspicion for Sarcoma: Clinical Presentation, Multi-Modality Imaging Evaluation, and Ultrasound Artificial Intelligence-Based Decision Support
– Cancers (Open Access)
Breast Lymphoma: Imaging Features, Clinical Presentation, and Ultrasound Artificial Intelligence Decision Support
– Clinical Imaging
Artificial Intelligence for Assessment of Digital Mammography Positioning Reveals Persistent Challenges
– Journal of Breast Imaging
Breast Arterial Calcifications on Mammography: A Review of the Literature
– Review Article
Identifying Frequently Endorsed Benefits and Barriers to Breast Cancer Screening for African-Born Women in the NYC Metropolitan Area: A Pilot Study
– Journal of Racial and Ethnic Health Disparities
Low-Dose Chest CT: Participating in the Rise of Breast Density Awareness
– Journal of Women’s Health

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award | MD | Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished radiologist and internationally respected leader in breast imaging, currently serving as Professor and Vice Chair for Breast Imaging in the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, where she has made transformative contributions to breast cancer detection, digital imaging, and women’s health. Dr. Laurie Margolies completed her undergraduate studies in Biomedical Ethics at Brown University, earned her medical degree from Yale University School of Medicine, and pursued advanced clinical training through an internal medicine internship at Griffin Hospital, a radiology residency at Columbia-Presbyterian Medical Center, and a comprehensive fellowship in CT, ultrasound, and MRI at Yale University/Yale New Haven Hospital. Her professional experience spans decades of academic appointments, including Instructor at Yale, rising through faculty ranks at Mount Sinai from Assistant Professor to full Professor, while simultaneously serving as System Chief of Breast Imaging across multiple hospitals, Director of Breast Imaging at Mount Sinai Hospital, and Chief of Breast Imaging at the Dubin Breast Center. Dr. Laurie Margolies’s research interests center on breast cancer screening optimization, digital mammography, cardiovascular risk evaluation through mammographic arterial calcifications, health disparity reduction, culturally targeted education programs, imaging physics, AI-driven diagnostic tools, and cross-disciplinary cancer detection methods. Her research skills include expertise in multimodality breast imaging, tomosynthesis assessment, radiologic quality control, population-based screening program development, clinical guideline evaluation, and participation in collaborative research teams across oncology, epidemiology, psychology, and medical physics. She has contributed to impactful studies published in reputable journals such as the Journal of Breast Imaging, Clinical Imaging, Journal of Cancer Education, and PEC Innovation, and she has served on multiple advisory boards for leading medical technology companies, advancing AI-assisted imaging development. Dr. Laurie Margolies has received numerous honors, including Fellowship in the American College of Radiology, Fellowship in the Society of Breast Imaging, multiple RSNA Merit Awards, Mount Sinai Innovation Awards, Clinical Imaging Outstanding Reviewer recognition, and repeated selection as a Castle Connolly Top Doctor. She has served on key institutional committees, leadership panels, and mentoring programs, significantly shaping radiologic quality improvement and cancer screening strategies. Dr. Laurie Margolies continues to influence clinical practice through her dedication to research, patient-centered care, and educational advancement, embodying excellence in academic radiology and demonstrating ongoing potential to elevate global breast imaging standards.

Profile: ORCID | Google Scholar

Featured Publications 

  1. Margolies, L. R., Spear, G. G., Payne, J. I., Iles, S. E., & Abdolell, M. (2025). Artificial intelligence for assessment of digital mammography positioning reveals persistent challenges.

  2. Rossi, J., Cho, L., Newell, M. S., Venta, L. A., Montgomery, G. H., Destounis, S. V., Brem, R. F., Parghi, C., & Margolies, L. R. (2025). Breast arterial calcifications on mammography: A review of the literature.

  3. Mullen, L. A., Ambinder, E. B., Talati, N., & Margolies, L. R. (2023). Mammography information systems: A survey of breast imaging radiologist satisfaction and perspectives.

  4. Head, K. J., Harrington, N. G., Schnur, J. B., Margolies, L., & Montgomery, G. H. (2022). Examining gain- and loss-framed messages in a novel breast cancer screening/cardiovascular context: Does framing matter.

  5. Vang, S., Margolies, L. R., & Jandorf, L. (2022). Screening mammogram adherence in medically underserved women: Does language preference matter.

  6. Fung, J., Vang, S., Margolies, L. R., Li, A., Blondeau-Lecomte, E., Li, A., & Jandorf, L. (2021). Developing a culturally and linguistically targeted breast cancer educational program for a multicultural population.

  7. Margolies, L. R., Salvatore, M., Yip, R., Tam, K., Bertolini, A., Henschke, C., & Yankelevitz, D. (2018). The chest radiologist’s role in invasive breast cancer detection.

 

Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr . Christina Pettan-Brewer | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Christina Pettan-Brewer | Medicine and Health Sciences | Associate Professor and Director | School of Medicine University of Washington | United States

Associate Professor Dr. Christina Pettan-Brewer is a distinguished veterinary scientist and global health leader whose career bridges research, education, and international policy. With advanced training in veterinary medicine, genetics, epidemiology, and One Health, she has contributed significantly to understanding zoonotic diseases, environmental health, and the genetic and molecular mechanisms of aging and disease. She serves as a key advisor and expert for international organizations including UNEP Nature for Health, WHO, PREZODE, and the International Alliance against Health Risks in Wildlife Trade, demonstrating her influence on global health strategies and pandemic prevention platforms. As Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health, she plays a pivotal role in advancing interdisciplinary scientific communication. Multilingual and internationally engaged, she combines her academic role at the University of Washington with mentorship, Fulbright program leadership, and advocacy for underrepresented groups in science, making her a recognized authority in One Health, planetary health, and global public health innovation.

Professional Profile 

Education  

Associate Professor Dr. Christina Pettan-Brewer has a strong and diverse educational background that reflects her interdisciplinary expertise. She began her academic journey in Brazil, earning a technical degree in Zoology and Clinical Pathology, followed by a Doctor of Veterinary Medicine with honors from the Universidade Federal de Viçosa. She then pursued advanced studies in the United States at the University of California, Davis, completing a Master of Science in Wildlife and Zoological Medicine and Comparative Pathology while also receiving accreditation as a Doctor of Veterinary Medicine. To further strengthen her expertise in global health, she obtained a PhD in One Health and Global Health from the Federal University of Paraná in collaboration with the University of Colorado, specializing in Indigenous Health and Emerging Infectious Diseases. Her educational achievements, marked by honors and top performance, form the foundation of her career in veterinary medicine, public health, genetics, and planetary health.

Professional Experience

Associate Professor Dr. Christina Pettan-Brewer has built an impressive professional career that integrates academic leadership, research, and international advisory roles. She began her faculty journey as an Assistant Professor at Centenary University in New Jersey, where she developed curricula for pre-veterinary and pre-medicine programs while conducting research on avian pathology during the West Nile Virus outbreak. At the University of Washington School of Medicine, she has advanced through roles as Acting Instructor, Acting Assistant Professor, and now Associate Professor in the Department of Comparative Medicine, contributing extensively to research in genetics, zoonotic diseases, and One Health. Beyond academia, she has served as a senior advisor and technical expert for global organizations such as UNEP, WHO, PREZODE, and international veterinary associations, shaping global health strategies and pandemic preparedness. Her editorial leadership with CABI One Health and Beyond One Ocean Health further demonstrates her influence in scientific communication, while her Fulbright program advisory role highlights her dedication to mentoring and international academic exchange.

Research Interest

Associate Professor Dr. Christina Pettan-Brewer’s research interests lie at the intersection of veterinary medicine, public health, and planetary health, with a strong emphasis on the One Health approach. She focuses on zoonotic and emerging infectious diseases, pandemic prevention, and the interconnectedness of human, animal, and environmental health. Her work extends to the genetic and molecular mechanisms of aging, chronic diseases, and susceptibility to toxins, as well as the health impacts of climate change and biodiversity loss. She is particularly interested in Indigenous health, global health equity, and the role of wildlife and ecosystem preservation in preventing future pandemics. Through her interdisciplinary research, she seeks to advance collaborative solutions that strengthen global health systems, protect vulnerable populations, and promote sustainable, resilient communities

Award and Honor

Associate Professor Dr. Christina Pettan-Brewer has been recognized with numerous honors and prestigious appointments that highlight her global leadership in One Health and public health. She has served as a United Nations Environment Programme (UNEP) One Health Expert and Technical Advisory Group member for the Nature for Health initiative, representing Latin America and later co-chairing its expert committee. Her expertise has been sought by the World Health Organization’s Global Preparedness Monitoring Board, PREZODE’s International Data Working Group, and the Agence Nationale de la Recherche in France for evaluating pandemic prevention strategies. She has also been appointed as a Fulbright Program Adviser, National Scholar Program Ambassador, and Reviewer, reflecting her commitment to international education and research exchange. In addition, her editorial leadership roles as Senior Editor of CABI One Health and Editor-in-Chief of Beyond One Ocean Health stand as significant honors that demonstrate her influence in shaping global scientific dialogue. These achievements collectively underscore her distinguished reputation as a trusted advisor, scholar, and thought leader in global health.

Publications Top Noted

Effects of Covid-19 Pandemic in the Surveillance and Control of Neglected Tropical Diseases and Malaria: A Systematic Review

Year: 2025

Protecting Urban Wildlife Fauna, Fighting Zoonoses, and Preventing Biophobia in Brazil

Year: 2025

Conclusion

Dr. Christina Pettan-Brewer is a highly suitable candidate for the Best Researcher Award. Her career exemplifies global leadership, interdisciplinary research, and a strong commitment to advancing One Health, pandemic prevention, and planetary health. With a proven record of academic excellence, international collaboration, and impactful advisory roles, she stands out as a researcher whose work bridges science, policy, and education. Addressing minor improvements related to visibility of individual research outputs would further strengthen her profile, but her broad and meaningful contributions make her a compelling and deserving nominee for this recognition.

 

Xiaodan Zhang | Medicine and Health Sciences | Best Researcher Award Medicine and Health Sciences

Published on by Research Hypothesis

Assoc. Prof. Dr. Xiaodan Zhang | Medicine and Health Sciences | Best Researcher Award

Medicine and Health Sciences College of Life and Science Zhejiang Sci-Tech University, China      

Dr. Xiaodan Zhang is an accomplished Associate Professor at the College of Life Science and Medicine, with a Ph.D. in Pharmacy from Chung-Ang University (2013). With over a decade of academic and research experience, she has made significant contributions to the fields of pharmacognosy, natural product chemistry, and metabolomics. Her research focuses on the spatial distribution and pharmacological properties of bioactive compounds using advanced techniques like UPLC-Q-TOF-MS and DESI-MSI. Dr. Zhang has published extensively in high-impact journals such as Horticulture Research, Food Chemistry, and Molecules, often serving as corresponding author. Her work is characterized by a strong interdisciplinary approach, combining omics technologies and mass spectrometry to uncover therapeutic potentials of traditional medicinal plants. Despite limited mention of major awards or grants, her consistent publication record, scientific rigor, and collaborative projects establish her as a highly credible and forward-thinking researcher in the biomedical sciences.

Professional Profile 

🎓 Education Background of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang holds a distinguished academic background in the field of Pharmacy. She earned her Doctor of Philosophy (Ph.D.) in Pharmacy in 2013 from Chung-Ang University, South Korea—an institution recognized for its excellence in pharmaceutical sciences and biomedical research. Her doctoral studies laid the foundation for her future work in natural product pharmacology and metabolomics, equipping her with advanced knowledge in analytical chemistry, drug discovery, and plant-based therapeutic research. Her academic journey reflects a strong commitment to scientific inquiry and innovation.

💼 Professional Experience of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang has over a decade of dedicated academic and research experience in the biomedical sciences. She began her professional journey as an Assistant Professor at the College of Life Science and Medicine in 2013, a role she held for five years. In 2019, she was promoted to the position of Associate Professor, reflecting her growing leadership and contributions in research and teaching. Over these ten years, Dr. Zhang has been actively involved in advanced pharmacological studies, curriculum development, and interdisciplinary research collaborations. Her experience underscores a strong progression in academic ranks and a sustained commitment to excellence in the fields of pharmacy, life sciences, and medicinal chemistry.

🔬 Research Interests of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang’s research interests lie at the intersection of natural product pharmacology, metabolomics, and multi-omics integration. She is particularly focused on exploring the chemical composition, spatial distribution, and pharmacological activity of traditional medicinal plants using advanced analytical tools such as UPLC-Q-TOF-MS, DESI-MSI, and network pharmacology. Her work aims to identify bioactive compounds with anti-cancer, anti-inflammatory, antioxidant, and neuroprotective properties. By combining spectrum-effect relationships with high-resolution mass spectrometry, Dr. Zhang contributes to the scientific validation and modernization of herbal medicines. Her research not only advances fundamental knowledge in pharmaceutical sciences but also supports the development of safer and more effective therapeutic agents from natural sources.

🏅 Awards and Honors of Dr. Xiaodan Zhang

Dr. Xiaodan Zhang has earned recognition for her dedicated contributions to the fields of pharmacy, metabolomics, and traditional medicine research. While specific awards and honors are not detailed in her current CV, her consistent authorship in high-impact journals such as Horticulture Research, Food Chemistry, and Molecules reflects a high level of academic distinction and peer recognition. Her role as a corresponding author on multiple publications and her advancement to Associate Professor further underscore the esteem she holds within the scientific community. As her research continues to gain traction globally, Dr. Zhang is well-positioned for future honors and prestigious research accolades in the biomedical and pharmaceutical sciences.

🏁 Conclusion

Dr. Xiaodan Zhang demonstrates strong suitability for the Best Researcher Award in Pharmacy or Life Sciences. Her profile reflects a high-caliber researcher with solid academic credentials, prolific publication output in impactful journals, and an evident commitment to advancing research in natural product pharmacology and metabolomics.

📚 Publications Top Note

  1. Title: Alternaria alstroemeriae F1 inhibits Aspergillus flavus growth and weakens aflatoxins biosynthesis
    Authors: [Not fully listed in your input]
    Journal: Fungal Genetics and Biology
    Year: 2025
    Citations: 0

  2. Title: Medicinal and edible homologous poly/oligo-saccharides: Structural features, effect on intestinal flora and preventing and treating type 2 diabetes, and their applications: A review
    Authors: [Not fully listed in your input]
    Type: Review Article
    Year: 2025
    Citations: 0

  3. Title: Directed evolution of diacylglycerol acyltransferases 2 promotes lipids and triglyceride accumulation
    Authors: [Not fully listed in your input]
    Journal: Plant Molecular Biology
    Year: 2025
    Citations: 0

  4. Title: Exploring the Metabolic and Transcriptomic Profiles of Tetrastigma hemsleyanum for Tissue-Specific Compound Accumulation
    Authors: [Not fully listed in your input]
    Journal: Frontiers in Plant Science
    Year: 2025
    Open Access: 
    Citations: 0

  5. Title: Analysis of the correlation between the distribution of microorganisms carried by Coix seed and fungal toxins, and the biological control of aflatoxin
    Authors: [Not fully listed in your input]
    Journal: Current Research in Food Science
    Year: 2025
    Open Access: 
    Citations: 0

 

 

Gao Jianhong | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Gao Jianhong | Medicine and Health Sciences | Best Researcher Award

Dr Jianhong Gao, upm, Malaysia

Dr. Jianhong Gao is a dedicated sports scientist and research fellow at the National Sports Institute of Malaysia, specializing in injury prevention, rehabilitation, and musculoskeletal health. She holds a bachelor’s degree from First Shandong Medical University, a master’s in sports rehabilitation from Shanghai University of Sport, and a PhD in sports science from Universiti Putra Malaysia. Her expertise lies in developing rehabilitation strategies for elite athletes, focusing on chronic low back pain, biomechanics, and return-to-play protocols. With multiple high-impact publications and funded research projects, she has significantly contributed to the advancement of sports rehabilitation. Dr. Gao collaborates with leading universities and institutions, ensuring evidence-based clinical applications. She is an advocate for innovative rehabilitation techniques like tissue flossing and biomechanical assessment to enhance athletic performance and reduce injury risks. Her research has shaped modern approaches in sports medicine, benefitting both professional athletes and the general population.

Publication Profile

Google Scholar

Education

Dr. Jianhong Gao has a strong academic background in sports science and rehabilitation. She earned her bachelor’s degree in medical sciences from First Shandong Medical University, laying the foundation for her expertise in human physiology and sports medicine. She then pursued a master’s degree in sports rehabilitation from Shanghai University of Sport, where she gained advanced knowledge in musculoskeletal health and injury recovery. Furthering her academic journey, she obtained a PhD in sports science from Universiti Putra Malaysia, focusing on injury prevention and rehabilitation for elite athletes. Her research integrates biomechanics, tissue flossing, and rehabilitation therapy to optimize athletic performance and recovery. Throughout her studies, she engaged in extensive clinical research and collaborated with top experts, shaping her evidence-based approach to sports injury management. Dr. Gao’s academic achievements highlight her commitment to advancing sports science and developing innovative rehabilitation methodologies for athletes worldwide.

Experience

Dr. Jianhong Gao has extensive experience in sports injury prevention and rehabilitation. She is currently a Research Fellow at the National Sports Institute of Malaysia, where she specializes in injury management and performance optimization for elite athletes. She has led multiple funded research projects, including studies on chronic low back pain rehabilitation, biomechanical assessments in martial arts, and injury risk management programs. Her work has contributed to innovative rehabilitation protocols and return-to-play strategies. Dr. Gao actively collaborates with Universiti Malaya, Universiti Putra Malaysia, and Tunku Abdul Rahman University to advance sports science research. She also provides consultation on musculoskeletal disorders for athletes and the general public, integrating biomechanics, myofascial release, and corrective exercises. With a strong academic and clinical background, she continues to bridge the gap between research and practical applications in sports medicine, helping athletes recover efficiently and perform at their peak.

Awards and Honors

Dr. Jianhong Gao’s contributions to sports science and rehabilitation have earned her significant recognition. She has received multiple research grants, including RM100,000 for her study on Flossband rehabilitation for chronic low back pain and RM35,000 for research on karate punching biomechanics. Additionally, she is a key investigator in a RM2.5 million injury risk management project (2024-2027). Her research has been published in prestigious journals indexed in Scopus and SCI, reflecting her expertise in sports injury prevention. Dr. Gao has collaborated with leading universities and sports institutions, further enhancing her impact in the field. Her studies on tissue flossing, biomechanics, and rehabilitation techniques have influenced clinical applications worldwide. As a leading researcher in sports medicine, she has played a crucial role in advancing rehabilitation strategies, making her a deserving candidate for the Best Researcher Award for her outstanding academic and scientific contributions.

Research Focus

Dr. Jianhong Gao’s research revolves around sports injury prevention, chronic low back pain management, and return-to-play strategies. She specializes in biomechanics, myofascial release techniques, and rehabilitation protocols to improve athletic performance and recovery. One of her key research areas is the use of Flossband therapy for musculoskeletal rehabilitation, which she has explored through clinical trials. She has also conducted extensive studies on karate punching biomechanics and strength assessments in elite martial artists. Her work emphasizes evidence-based rehabilitation strategies, integrating tissue flossing, biomechanical analysis, and corrective exercises to minimize injury risks. As an investigator in a multi-million-ringgit injury risk management project, she aims to develop a comprehensive injury prevention framework for professional athletes. Her findings have been instrumental in shaping modern rehabilitation techniques, benefiting not only elite athletes but also individuals suffering from musculoskeletal conditions.

Publication Top Notes

The effect of tissue flossing technique on sports and injury prevention and rehabilitation: a systematic review of recent research

Absolute Reliability and Concurrent Validity of the Modified Goniometric Platform for Measuring Trunk Rotation in the Sitting Position

The potential mechanisms of tissue flossing with Flossband application around the joints or soft tissues: A theoretical framework

Social capital and physical activity: A literature review up to march 2024

Multivariate regression modeling of Chinese artistic gymnastic handspring vaulting kinematic performance based on judges scores

Exploring the role of social capital in enhancing physical activity among college and university students: A systematic review

Comprehensive analysis of college students’ autonomous fitness behavior—a narrative review

 

 

 

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Published on by Research Hypothesis

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year 🏆 (Miller School of Medicine, 2015), the Outstanding Care Award 🏅 (Sarcoma Alliance, 2012), and the Leadership in Clinical Research 🎖️ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER